Effects of GH/IGF on the Aging Mitochondria

The mitochondria are key organelles regulating vital processes in the eukaryote cell. A decline in mitochondrial function is one of the hallmarks of aging. Growth hormone (GH) and the insulin-like growth factor-1 (IGF-1) are somatotropic hormones that regulate cellular homeostasis and play significant roles in cell differentiation, function, and survival. In mammals, these hormones peak during puberty and decline gradually during adulthood and aging. Here, we review the evidence that GH and IGF-1 regulate mitochondrial mass and function and contribute to specific processes of cellular aging. Specifically, we discuss the contribution of GH and IGF-1 to mitochondrial biogenesis, respiration and ATP production, oxidative stress, senescence, and apoptosis. Particular emphasis was placed on how these pathways intersect during aging.

[1]  E. Verschueren,et al.  Dynamic Regulation of Mitochondrial Import by the Ubiquitin System. , 2020, Molecular cell.

[2]  E. Hascup,et al.  Lifespan of long‐lived growth hormone receptor knockout mice was not normalized by housing at 30°C since weaning , 2020, Aging cell.

[3]  R. O'Connor,et al.  IGF-1 Signalling Regulates Mitochondria Dynamics and Turnover through a Conserved GSK-3β–Nrf2–BNIP3 Pathway , 2020, Cells.

[4]  M. Kinter,et al.  Disparate Central and Peripheral Effects of Circulating IGF-1 Deficiency on Tissue Mitochondrial Function , 2019, Molecular Neurobiology.

[5]  N. Burd,et al.  The Role of the IGF-1 Signaling Cascade in Muscle Protein Synthesis and Anabolic Resistance in Aging Skeletal Muscle , 2019, Front. Nutr..

[6]  N. Musi,et al.  The enigmatic role of growth hormone in age-related diseases, cognition, and longevity , 2019, GeroScience.

[7]  F. Otsuka,et al.  Clinical relevance of insulin-like growth factor-1 to cardiovascular risk markers , 2019, The aging male : the official journal of the International Society for the Study of the Aging Male.

[8]  P. Moraes-Vieira,et al.  Mitochondria as central hub of the immune system , 2019, Redox biology.

[9]  Xiaoke Jiang,et al.  Insulin-like growth factor-1 attenuates oxidative stress-induced hepatocyte premature senescence in liver fibrogenesis via regulating nuclear p53–progerin interaction , 2019, Cell Death & Disease.

[10]  D. Finlay,et al.  Immunometabolism and natural killer cell responses , 2019, Nature Reviews Immunology.

[11]  A. Larbi,et al.  Relationships Between Ion Channels, Mitochondrial Functions and Inflammation in Human Aging , 2019, Front. Physiol..

[12]  Elias S. J. Arnér,et al.  Absence of TXNIP in Humans Leads to Lactic Acidosis and Low Serum Methionine Linked to Deficient Respiration on Pyruvate , 2019, Diabetes.

[13]  Xi Wang,et al.  Evidence that growth hormone can improve mitochondrial function in oocytes from aged mice , 2019, Reproduction.

[14]  F. Scaglia,et al.  Mitochondrial dynamics: Biological roles, molecular machinery, and related diseases. , 2018, Molecular genetics and metabolism.

[15]  G. Billman,et al.  Inflammation–Nature's Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing “the Epidemic” of Chronic Diseases , 2018, Front. Med..

[16]  R. Hartley,et al.  Mitochondria as a therapeutic target for common pathologies , 2018, Nature Reviews Drug Discovery.

[17]  Thomas A. Slater,et al.  The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes , 2018, Molecular metabolism.

[18]  Yimin Fang,et al.  Increased environmental temperature normalizes energy metabolism outputs between normal and Ames dwarf mice , 2018, Aging.

[19]  H. Werner,et al.  Mitochondrial Function Is Compromised in Cortical Bone Osteocytes of Long‐Lived Growth Hormone Receptor Null Mice , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  F. Hakuno,et al.  IGF1 receptor signaling pathways. , 2018, Journal of molecular endocrinology.

[21]  W. Freeman,et al.  Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-β uptake in astrocytes , 2018, Molecular metabolism.

[22]  D. Gurwitz,et al.  Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action , 2018, Proceedings of the National Academy of Sciences.

[23]  Alexander V. Zhdanov,et al.  Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells , 2017, The Journal of Biological Chemistry.

[24]  I. Castilla-Cortázar,et al.  The single IGF-1 partial deficiency is responsible for mitochondrial dysfunction and is restored by IGF-1 replacement therapy. , 2017, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[25]  P. Schaik,et al.  Inflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders? , 2017, Neuroscience Letters.

[26]  L. Cantley,et al.  Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin. , 2017, Cell reports.

[27]  N. Barzilai,et al.  The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future Research. , 2016, Cell metabolism.

[28]  D. Gurwitz,et al.  Identification of signaling pathways associated with cancer protection in Laron syndrome. , 2016, Endocrine-related cancer.

[29]  A. Klochendler,et al.  p16Ink4a-induced senescence of pancreatic beta cells enhances insulin secretion , 2016, Nature Medicine.

[30]  Laura C. Greaves,et al.  Mitochondria are required for pro‐ageing features of the senescent phenotype , 2016, The EMBO journal.

[31]  C. Farquharson,et al.  Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions. , 2016, Endocrine reviews.

[32]  Wolfgang Link,et al.  Long live FOXO: unraveling the role of FOXO proteins in aging and longevity , 2015, Aging cell.

[33]  S. Yamada,et al.  Accelerated Telomere Shortening in Acromegaly; IGF-I Induces Telomere Shortening and Cellular Senescence , 2015, PloS one.

[34]  T. Hagen,et al.  2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells. , 2015, Biochemical and biophysical research communications.

[35]  A. Bartke,et al.  Growth hormone modulates hypothalamic inflammation in long‐lived pituitary dwarf mice , 2015, Aging cell.

[36]  Ling Zhao,et al.  Inflammatory responses and inflammation-associated diseases in organs , 2015, Oncotarget.

[37]  N. Sharpless,et al.  Forging a signature of in vivo senescence , 2015, Nature Reviews Cancer.

[38]  F. Puglisi,et al.  Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells. , 2015, Oncology reports.

[39]  KimSo-Hee,et al.  Incorporation of Human Growth Hormone-2 into Proteoliposome Enhances Tissue Regeneration with Anti-Oxidant and Anti-Senescence Activities , 2015 .

[40]  H. Brown-Borg,et al.  Growth hormone alters the glutathione S-transferase and mitochondrial thioredoxin systems in long-living Ames dwarf mice. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[41]  J. Viña,et al.  Growth hormone replacement therapy prevents sarcopenia by a dual mechanism: improvement of protein balance and of antioxidant defenses. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[42]  S. Orrù,et al.  Insulin‐like growth factor 1 receptor signaling induced by supraphysiological doses of IGF‐1 in human peripheral blood lymphocytes , 2014, Proteomics.

[43]  A. Oberg,et al.  Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in mice , 2014, Aging.

[44]  A. Shalev.  Minireview: Thioredoxin-interacting protein: regulation and function in the pancreatic β-cell. , 2014, Molecular endocrinology.

[45]  Z. Xiao,et al.  Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence , 2014, Aging cell.

[46]  V. Skulachev,et al.  Antioxidant SkQ1 delays sarcopenia-associated damage of mitochondrial ultrastructure , 2014, Aging.

[47]  J. Yodoi,et al.  Thioredoxin/Txnip: Redoxisome, as a Redox Switch for the Pathogenesis of Diseases , 2014, Front. Immunol..

[48]  S. Melmed,et al.  Growth hormone is a cellular senescence target in pituitary and nonpituitary cells , 2013, Proceedings of the National Academy of Sciences.

[49]  M. Kuro-o,et al.  Amadori products promote cellular senescence activating insulin-like growth factor-1 receptor and down-regulating the antioxidant enzyme catalase. , 2013, The international journal of biochemistry & cell biology.

[50]  Kelly J. Morris,et al.  A complex secretory program orchestrated by the inflammasome controls paracrine senescence , 2013, Nature Cell Biology.

[51]  Jianbiao Zhou,et al.  Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer. , 2013, Mitochondrion.

[52]  V. Skulachev,et al.  The mitochondria-targeted antioxidant SkQ1 but not N-acetylcysteine reverses aging-related biomarkers in rats , 2012, Aging.

[53]  G. Iguchi,et al.  IGF-I enhances cellular senescence via the reactive oxygen species-p53 pathway. , 2012, Biochemical and biophysical research communications.

[54]  S. N. Murthy,et al.  Aging alters tissue resident mesenchymal stem cell properties. , 2012, Stem cell research.

[55]  Jun Ren,et al.  Insulin-Like Growth Factor 1 Alleviates High-Fat Diet–Induced Myocardial Contractile Dysfunction: Role of Insulin Signaling and Mitochondrial Function , 2012, Hypertension.

[56]  R. S. Sohal,et al.  The redox stress hypothesis of aging. , 2012, Free radical biology & medicine.

[57]  H. Brown-Borg,et al.  Expression of oxidative phosphorylation components in mitochondria of long-living Ames dwarf mice , 2012, AGE.

[58]  F. Baron,et al.  Expression of the Growth Hormone/Insulin-Like Growth Factor Axis during Balb/c Thymus Ontogeny and Effects of Growth Hormone upon ex vivo T Cell Differentiation , 2012, Neuroimmunomodulation.

[59]  A. Bartke,et al.  Growth hormone, inflammation and aging , 2012, Pathobiology of aging & age related diseases.

[60]  J. Campisi,et al.  Tumor Suppressor and Aging Biomarker p16INK4a Induces Cellular Senescence without the Associated Inflammatory Secretory Phenotype* , 2011, The Journal of Biological Chemistry.

[61]  M. Adamo,et al.  Increased serum IGF‐1 levels protect the musculoskeletal system but are associated with elevated oxidative stress markers and increased mortality independent of tissue igf1 gene expression , 2011, Aging cell.

[62]  V. Hwa,et al.  Acid-labile subunit (ALS) deficiency. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[63]  Terry J. Smith.  Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases? , 2010, Pharmacological Reviews.

[64]  K. Webster,et al.  Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells , 2010, BMC Genomics.

[65]  R. Medzhitov.  Inflammation 2010: New Adventures of an Old Flame , 2010, Cell.

[66]  M. Esteban,et al.  A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history , 2010, Virology Journal.

[67]  R. DePinho,et al.  FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. , 2010, Cell metabolism.

[68]  A. Lloyd,et al.  Extracellular growth factors and mitogens cooperate to drive mitochondrial biogenesis , 2009, Journal of Cell Science.

[69]  A. Shalev,et al.  Intracellular Shuttling and Mitochondrial Function of Thioredoxin-interacting Protein* , 2009, The Journal of Biological Chemistry.

[70]  M. Adamo,et al.  PI3K p110α and p110β have differential effects on Akt activation and protection against oxidative stress-induced apoptosis in myoblasts , 2009, Cell Death and Differentiation.

[71]  J. Walston,et al.  Serum markers of apoptosis decrease with age and cancer stage , 2009, Aging.

[72]  J. Campisi,et al.  Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion , 2009, Nature Cell Biology.

[73]  A. Bartke,et al.  Alterations in oxygen consumption, respiratory quotient, and heat production in long-lived GHRKO and Ames dwarf mice, and short-lived bGH transgenic mice. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[74]  A. Bartke,et al.  Long-living growth hormone receptor knockout mice: Potential mechanisms of altered stress resistance , 2009, Experimental Gerontology.

[75]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[76]  S. Austad,et al.  Endothelial function and vascular oxidative stress in long‐lived GH/IGF‐deficient Ames dwarf mice , 2008, American journal of physiology. Heart and circulatory physiology.

[77]  D. Peeper,et al.  Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network , 2008, Cell.

[78]  J. Muntané,et al.  Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats. , 2008, Endocrinology.

[79]  M. García-Fernández,et al.  Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats. , 2008, Endocrinology.

[80]  D. Tindall,et al.  FOXOs, cancer and regulation of apoptosis , 2008, Oncogene.

[81]  Richard T. Lee,et al.  Thioredoxin-interacting Protein (Txnip) Is a Critical Regulator of Hepatic Glucose Production* , 2008, Journal of Biological Chemistry.

[82]  L. Roberts,et al.  Lower levels of F2-isoprostanes in serum and livers of long-lived Ames dwarf mice. , 2007, Biochemical and biophysical research communications.

[83]  J. Campisi,et al.  Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.

[84]  Antony Rodriguez,et al.  Noncanonical cell death pathways act during Drosophila oogenesis , 2007, Genesis.

[85]  P. Poole‐Wilson,et al.  Age-Dependent Impairment of Endothelial Progenitor Cells Is Corrected by Growth Hormone Mediated Increase of Insulin-Like Growth Factor-1 , 2007, Circulation research.

[86]  Yonghong Xiao,et al.  FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis , 2007, Cell.

[87]  Richard T. Lee,et al.  The Interaction of Thioredoxin with Txnip , 2006, Journal of Biological Chemistry.

[88]  P. Houghton,et al.  IGF-I mediated survival pathways in normal and malignant cells. , 2006, Biochimica et biophysica acta.

[89]  V. Ray,et al.  Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse. , 2005, Endocrinology.

[90]  T. Niu,et al.  The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. , 2005, Gene.

[91]  K. Rosenblatt,et al.  Regulation of Oxidative Stress by the Anti-aging Hormone Klotho*♦ , 2005, Journal of Biological Chemistry.

[92]  C. Kendziorski,et al.  Gene expression profiling in INS-1 cells overexpressing thioredoxin-interacting protein. , 2005, Biochemical and biophysical research communications.

[93]  A. Salmon,et al.  Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress. , 2005, American journal of physiology. Endocrinology and metabolism.

[94]  Z. Laron,et al.  Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. , 2004, The Journal of clinical endocrinology and metabolism.

[95]  D. Yellon,et al.  New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. , 2004, Cardiovascular research.

[96]  D. Dorscheid,et al.  Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury , 2003, Critical care.

[97]  Cori Bargmann,et al.  Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans , 2003, Nature.

[98]  Jun Ho Jeon,et al.  VDUP1 upregulated by TGF-β1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression , 2003, Oncogene.

[99]  E. Arvat,et al.  Endocrine and Non-Endocrine Actions of Ghrelin , 2003, Hormone Research in Paediatrics.

[100]  D. Butterfield,et al.  The antioxidants α‐lipoic acid and N‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice , 2003, Journal of neurochemistry.

[101]  Martin Holzenberger,et al.  IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice , 2003, Nature.

[102]  M. Papotti,et al.  Ghrelin: endocrine and non-endocrine actions. , 2002, Journal of pediatric endocrinology & metabolism : JPEM.

[103]  E. Arvat,et al.  Ghrelin and synthetic GH secretagogues. , 2002, Best practice & research. Clinical endocrinology & metabolism.

[104]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[105]  A. Bartke,et al.  Antioxidant enzymes, free-radical damage, and response to paraquat in liver and kidney of long-living growth hormone receptor/binding protein gene-disrupted mice. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[106]  H. Brown-Borg,et al.  Mitochondrial oxidant generation and oxidative damage in Ames dwarf and GH transgenic mice , 2001, Journal of the American Aging Association.

[107]  W. Zong,et al.  BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. , 2001, Genes & development.

[108]  P. Anversa,et al.  IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. , 2001, Diabetes.

[109]  M. Tatar,et al.  A Mutant Drosophila Insulin Receptor Homolog That Extends Life-Span and Impairs Neuroendocrine Function , 2001, Science.

[110]  K. Webster,et al.  Reperfusion-Activated Akt Kinase Prevents Apoptosis in Transgenic Mouse Hearts Overexpressing Insulin-Like Growth Factor-1 , 2001, Circulation research.

[111]  N. Holbrook,et al.  Oxidants, oxidative stress and the biology of ageing , 2000, Nature.

[112]  K. Davies,et al.  Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.

[113]  A. Bartke,et al.  Effects of growth hormone on hypothalamic catalase and Cu/Zn superoxide dismutase1 , 2000 .

[114]  A. Bode,et al.  Antioxidative mechanisms and plasma growth hormone levels , 1999, Endocrine.

[115]  P. Cohen,et al.  Phosphorylation of Serine 256 by Protein Kinase B Disrupts Transactivation by FKHR and Mediates Effects of Insulin on Insulin-like Growth Factor-binding Protein-1 Promoter Activity through a Conserved Insulin Response Sequence* , 1999, The Journal of Biological Chemistry.

[116]  F. Lezoualc’h,et al.  Insulin-like Growth Factor-1-mediated Neuroprotection against Oxidative Stress Is Associated with Activation of Nuclear Factor κB* , 1999, The Journal of Biological Chemistry.

[117]  M. Brooke,et al.  Neurotrophic factors decrease the release of creatine kinase and prostaglandin E2 from metabolically stressed muscle , 1998, Neuromuscular Disorders.

[118]  Koutarou D. Kimura,et al.  daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. , 1997, Science.

[119]  K. Kinzler,et al.  Less death in the dying , 1997, Cell Death and Differentiation.

[120]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[121]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[122]  C. Winterbourn.  Toxicity of iron and hydrogen peroxide: the Fenton reaction. , 1995, Toxicology letters.

[123]  C. Kenyon,et al.  A C. elegans mutant that lives twice as long as wild type , 1993, Nature.

[124]  G. Novelli,et al.  Laron dwarfism and mutations of the growth hormone-receptor gene. , 1989, The New England journal of medicine.

[125]  L. Meacham,et al.  Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[126]  B. Husman,et al.  Thyroid hormone and not growth hormone is the principle regulator of mammalian mitochondrial biogenesis. , 1989, Acta endocrinologica.

[127]  J. Blalock,et al.  Expression of growth hormone by lymphocytes. , 1989, International reviews of immunology.

[128]  M J Banda,et al.  Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. , 1988, Science.

[129]  I. Fridovich.  Biological effects of the superoxide radical. , 1986, Archives of biochemistry and biophysics.

[130]  R. McCARTER,et al.  The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. , 1985, The Journal of clinical endocrinology and metabolism.

[131]  P. Collipp,et al.  Effect of growth hormone on mitochondrial protein synthesis. , 1973, The Journal of biological chemistry.

[132]  G. S. Bayse,et al.  Subcellular distribution of 125I-labeled bovine growth hormone in rat liver and kidney , 1972 .

[133]  Denham Harman,et al.  The Biologic Clock: The Mitochondria? , 1972, Journal of the American Geriatrics Society.

[134]  W. Daughaday,et al.  Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. , 1971, The Journal of clinical endocrinology and metabolism.

[135]  A. Pertzelan,et al.  Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism? , 1966, Israel journal of medical sciences.

[136]  M. Niedziela,et al.  PAPP-A2 a new key regulator of growth. , 2017, Endokrynologia Polska.

[137]  Ho-Shik Kim,et al.  Deletion of IGF-1 Receptors in Cardiomyocytes Attenuates Cardiac Aging in Male Mice. , 2016, Endocrinology.

[138]  W. Craigen.  Mitochondrial DNA mutations: an overview of clinical and molecular aspects. , 2012, Methods in molecular biology.

[139]  J. Baker,et al.  Changes in Endothelial Dysfunction and Associated Cardiovascular Disease Morbidity Markers in GH-IGF Axis Pathology , 2009, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[140]  A. Strasser,et al.  The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.

[141]  Andrzej Bartke,et al.  Life extension in the dwarf mouse. , 2004, Current topics in developmental biology.

[142]  B. Han,et al.  Aging alters the apoptotic response to genotoxic stress , 2002, Nature Medicine.

[143]  P. Douglas,et al.  Importance of an intact growth hormone/insulin-like growth factor 1 axis for normal post-infarction healing: studies in dwarf rats. , 2001, Endocrinology.

[144]  A. Bartke,et al.  Effects of growth hormone on hypothalamic catalase and Cu/Zn superoxide dismutase. , 2000, Free radical biology & medicine.

[145]  F. Lezoualc’h,et al.  Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB. , 1999, The Journal of biological chemistry.

[146]  G. S. Bayse,et al.  Subcellular distribution of 125 I-labeled bovine growth hormone in rat liver and kidney. , 1972, Biochimica et biophysica acta.